Maritime Health Research and Education-NET/DM2/Ten years plans
Appearance
TABLE 1. MAHRE-Net[1] Diabetes-2 draft research- and education plan
Organisation | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
Create international T2D maritime/transport workers research group | x | x | x | x | x | x | x | x | x | x |
Int. Guide Maritime T2D diagnostic, control, prevention (Appendix ) | x | x | x | |||||||
National/international Maritime/Transport T2D prevalence Register | x | x | x | x | ||||||
Joint ETF/ Euro-peche T2D maritime health promotion guides | x | x | x | x | x | x | x | x | x | x |
Epidemiological studies | ||||||||||
Monitoring prevalence T2D (repeated random sampling) | x | x | x | x | x | x | x | x | x | x |
Monitoring T2D complications and prevention guide | x | x | x | x | x | x | x | x | x | x |
Loss of working years for seafarers with T2D diagnose | x | x | x | |||||||
How to keep working at sea with T2D | ||||||||||
Guide to manage T2D -workplace at sea IMO/ILO | x | x | x | x | ||||||
Best clinical practices for maritime T2D caretake | ||||||||||
Guidelines for best choice T2D diagnostics (A1C, FPG, OGTT) | x | x | ||||||||
Program for the newly diagnosed type 2 diabetes seafarers (ILO/IMO) | x | x | x | x | ||||||
Education: Best practices for care for T2D seafarers onshore/onboard | x | x | x | x | ||||||
Non-pharm maritime epidemiological intervention studies | ||||||||||
Review of effect workplace interventions T2D | x | x | x | x | x | x | x | x | x | x |
pilot intervention among seafarers with high risk | x | x | x | |||||||
Pharmacological maritime epidemiological Intervention studies | ||||||||||
Review methods and effect pharmacological intervention | x | x | x | x | x | x | x | x | x | x |
Review combined pharm and non-pharm prevention | x | x | x | x | ||||||
Protocol for combined pharm and non-pharm prevention | x | x | x | |||||||
Application for Funds (Novo-Nordic) | x | x | x | x | x | x | x | x | x | |
Maritime T2D legal matters | ||||||||||
Example of Work compensation for T2D | x |